Global Duchenne Muscular Dystrophy Therapeutics Market Primary and Secondary Research, Segmentation, Projections, SWOT Analysis and Forecast by 2022

OrbisResearch.com has published new research report on "Global Duchenne Muscular Dystrophy Therapeutics Market By Drug (Translarna, Emflaza, EXONDYS 51), By Therapeutic Approach (Steroid Therapy, Exon Skipping, Mutation Suppression) Forecast to 2022" to its database.

Dallas, United States - July 17, 2017 /MarketersMedia/ —

Duchenne Muscular Dystrophy (DMD) is a fatal genetic disorders diagnosed in children around the world. DMD is often referred to as orphan or rare diseases, as it affects only a small portion of the population, approximately 1 in every 3,500 live male births. However, various treatment approaches are available now-a-days that can inhibit progression of the disease. Amongst, the most attractive are molecular based therapies, such as mutation suppression or exon skipping. Moreover, there are many more drugs in various phases of clinical trials, which will help in the growth of this market.

Browse the report: http://www.orbisresearch.com/reports/index/global-duchenne-muscular-dystrophy-therapeutics-market-by-drug-translarna-emflaza-exondys-51-by-therapeutic-approach-steroid-therapy-exon-skipping-mutation-suppression-forecast-to-2022

According to RNCOS’ new research report “Global Duchenne Muscular Dystrophy Therapeutics Market By Drug (Translarna, Emflaza, EXONDYS 51), By Therapeutic Approach (Steroid Therapy, Exon Skipping, Mutation Suppression) Forecast to 2022”, the Duchenne Muscular Dystrophy Therapeutics industry can possibly turn into a multi-million dollar industry by the end of 2022, as new products, particularly those in the advanced stage of clinical studies or with pending approvals, may enter the market to boost the growth.

The Duchenne Muscular Dystrophy Therapeutics market has very few marketed products, such as Emflaza, Translarna, and EXONDYS 51. The market is majorly in the research phase, from which most of its revenue is generated. Therefore, a major focus has been on the ongoing clinical trials for the development of innovative products. In this context, the study provides a comprehensive overview of various aspects of the clinical trials in the Duchenne Muscular Dystrophy market, such as phases, geographies, etc. The report also provides the sales of major marketed Duchenne Muscular Dystrophy products, and the list of the products in clinical/pre-clinical research along with their clinical phases.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/333580

The report provides a detailed analysis of the current and future market scenario of the global Duchenne Muscular Dystrophy Therapeutics market. RNCOS, in its report, further covers insight about the major drivers and challenges, along with the latest trends and developments impacting the industry growth. In addition, the report also highlights various opportunities available for growth of the global Duchenne Muscular Dystrophy Therapeutics market. The report also provides insights regarding the strategies adopted by the players from 2015 to 2017 for enhancing their market share.
The segmentation of Duchenne Muscular Dystrophy Therapeutics market has been done on the basis of different therapeutic approaches and geographical regions. Primarily, the Duchenne Muscular Dystrophy Therapeutics market is dominated by mutation suppression and exon skipping approach, with several companies and academic institutions focusing on potential for each of these treatments.

Based on the geography, the market is divided into three regions, namely - North America, Europe, and Asia Pacific. There are several treatments for DMD that are approved or under review in the European Union or are expected to be under review by regulatory agencies in the near future. This is a major reason for the dominant position of Europe in the Duchenne Muscular Dystrophy market.

Buy the report@http://www.orbisresearch.com/contact/purchase/333580

The later part of the report discusses some of the prominent players in the global Duchenne Muscular Dystrophy Therapeutics market. The market share analysis of these players is also provided in the report. Furthermore, a brief business overview of each player has been provided along with their business segments, product portfolios and recent developments. Overall, the report will prove as a complete source of knowledge and analysis for clients and potential investors.

Major Points From The Table Of Contents:
Analyst View
Research Methodology
Duchenne Muscular Dystrophy (DMD): An Overview
Market Dynamics
Global Duchenne Muscular Dystrophy Therapeutics Market Outlook 2022
Approved Drugs
Market Segmentation by Therapeutic Approach
Market Segmentation by Geography
Clinical Trial Assessment & Pipeline Analysis
Industry Trends and Developments
Strategic Alliances
Competitive Landscape
Key Player Analysis

List of Figures:
Figure 5-1: Global - Duchenne Muscular Dystrophy Therapeutics Market (Million US$), 2016-2022
Figure 6-1: Global - Sales of EXONDYS 51 (Million US$), 2016
Figure 6-2: Global - Sales of Translarna (Million US$), 2014-2017
Figure 7-1: Global - Duchenne Muscular Dystrophy Therapeutics Market by Therapeutic Approach (%), 2016
Figure 7-2: Global - Mutation Suppression Market for Duchenne Muscular Dystrophy (Million US$), 2016-2022
Figure 7-3: Global - Steroid Therapy Market for Duchenne Muscular Dystrophy (Million US$), 2016-2022
Figure 7-4: Global - Exon Skipping Therapy Market for Duchenne Muscular Dystrophy (Million US$), 2016-2022
Figure 8-1: Global - Duchenne Muscular Dystrophy Therapeutics Market by Geography (%), 2016
Figure 8-2: Europe - Duchenne Muscular Dystrophy Therapeutics Market (Million US$), 2016-2022
Figure 8-3: North America - Duchenne Muscular Dystrophy Therapeutics Market (Million US$), 2016-2022
Figure 8-4: Asia Pacific - Duchenne Muscular Dystrophy Therapeutics Market (Million US$), 2016-2022

List of Tables:
Table 4-1: Grants for Duchenne Muscular Dystrophy
Table 4-2: Per-Patient Annual Costs of DMD, 2012
Table 6-1: Ongoing Trials for Emflaza
Table 6-2: Ongoing Trials for EXONDYS 51
Table 6-3: Ongoing Trials for Translarna
Table 7-1: Disease-Modifying Therapies for Duchenne Muscular Dystrophy
Table 9-1: Global Duchenne Muscular Dystrophy Therapeutics Pipeline

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Info:
Name: Hector Costello
Email: sales@orbisresearch.com
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600, Dallas, Texas – 75204, U.S.A.
Phone: +1 (214) 884-6817

Source URL: http://marketersmedia.com/global-duchenne-muscular-dystrophy-therapeutics-market-primary-and-secondary-research-segmentation-projections-swot-analysis-and-forecast-by-2022/217967

For more information, please visit http://www.orbisresearch.com/reports/index/global-duchenne-muscular-dystrophy-therapeutics-market-by-drug-translarna-emflaza-exondys-51-by-therapeutic-approach-steroid-therapy-exon-skipping-mutation-suppression-forecast-to-2022

Source: MarketersMedia

Release ID: 217967

Latest News

In Egypt, archaeologists find part of 4,000-year-old statue

Oct 18, 2017

CAIRO — Egypt says archaeologists have discovered the head of a wooden statue, likely belonging to a female regent who ruled the country more than 4,000 years ago. Wednesday's statement by the Antiquities Ministry says the artifact was found in the district of Saqqara, near the ancient Pyramids of Giza. It says the part of the statue is in poor condition and will have to undergo restoration The uncovered head is believed to depict Ankhesenpepi II, the mother of King Pepi II of the 6th dynasty who ascended to the throne at the age of six. She ruled Egypt as...

Lego unveils 'Women of NASA' set with astronauts, scientists

Oct 18, 2017

ENFIELD, Conn. — Lego has unveiled a set of figures celebrating the women of NASA. The 231-piece set features Sally Ride, the first American female astronaut, and Mae Jemison, the first black woman to travel in space. Also included in the set are figures of astronomer and educator Nancy Grace Roman and computer scientist Margaret Hamilton. Lego versions of the Space Shuttle Challenger, the Hubble Space telescope can be put together with the set. A miniature version of Hamilton's workspace at the Massachusetts Institute of Technology as she was programming software for the moon landing is also featured. The set...

Ultra-personal therapy: Gene tumor boards guide cancer care

Oct 18, 2017

SAN DIEGO — Doctors were just guessing a decade ago when they gave Alison Cairnes' husband a new drug they hoped would shrink his lung tumors. Now she takes it too, but the choice was no guesswork. Sophisticated gene tests suggested it would fight her gastric cancer, and they were right. Cancer patients increasingly are having their care guided by gene tumor boards, a new version of the hospital panels that traditionally decided whether surgery, radiation or chemotherapy would be best. These experts study the patient's cancer genes and match treatments to mutations that seem to drive the disease. "We...

Parts of unmanned Russian spaceship burn up over Dubai

Oct 18, 2017

DUBAI, United Arab Emirates — Parts of an unmanned Russian cargo spaceship burned across the night sky of the Arabian Peninsula, drawing gasps from Dubai to Riyadh before breaking up in the Earth's atmosphere and scattering in the Indian Ocean. The fiery end Monday night to parts of Progress MS-07 came as planned after it delivered 2.5 metric tons (2.75 tons) of water, food and scientific equipment to the astronauts aboard the International Space Station. But its 80-second appearance in the skies of the United Arab Emirates stunned onlookers in a region where Iran regularly test-fires ballistic missiles and Shiite...

US nuke waste repository in New Mexico will get more space

Oct 18, 2017

ALBUQUERQUE, N.M. — Workers are expected to begin mining operations at the U.S. nuclear waste dump in New Mexico for the first time in three years following a radiation release that contaminated part of the underground repository, the Energy Department said Tuesday. The work to carve out more disposal space from the ancient salt formation where the repository is located will begin later this fall and should be completed by 2020, the department said in a statement. Workers will remove more than 112,000 tons (101,605 metric tons) of salt, making way for seven disposal rooms. Each will have space for...

Search

Recent Discovery will take you to the captivating developments in science, technology, and the universe around us. We deliver to you the latest news, theories, and developments in the world of science.

Contact us: sales@recentdiscovery.com

Trending News

ScienceAgricultural ScienceArchaeologyAstronomy Press